vs
ATLANTIC AMERICAN CORP（AAME）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是ATLANTIC AMERICAN CORP的1.3倍（$69.8M vs $53.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 1.1%，领先383.0%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 20.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 7.2%）
大西洋电报公司成立于1856年11月6日，主要业务是铺设并运营跨大西洋商业电报电缆，这也是人类历史上第一条跨大西洋的电信通信链路。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
AAME vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.3倍
$53.8M
营收增速更快
RIGL
高出0.4%
20.8%
净利率更高
RIGL
高出383.0%
1.1%
两年增速更快
RIGL
近两年复合增速
7.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.8M | $69.8M |
| 净利润 | $577.0K | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 1.4% | 33.2% |
| 净利率 | 1.1% | 384.0% |
| 营收同比 | 20.8% | 21.2% |
| 净利润同比 | 128.9% | 1769.2% |
| 每股收益（稀释后） | $0.02 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AAMERIGL
| Q4 25 | — | $69.8M | ||
| Q3 25 | $53.8M | $69.5M | ||
| Q2 25 | $55.3M | $101.7M | ||
| Q1 25 | $50.1M | $53.3M | ||
| Q4 24 | $49.0M | $57.6M | ||
| Q3 24 | $44.5M | $55.3M | ||
| Q2 24 | $47.7M | $36.8M | ||
| Q1 24 | $47.0M | $29.5M |
净利润AAMERIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $577.0K | $27.9M | ||
| Q2 25 | $3.3M | $59.6M | ||
| Q1 25 | $802.0K | $11.4M | ||
| Q4 24 | $412.0K | $14.3M | ||
| Q3 24 | $-2.0M | $12.4M | ||
| Q2 24 | $-684.0K | $-1.0M | ||
| Q1 24 | $-2.0M | $-8.2M |
毛利率AAMERIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率AAMERIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | 1.4% | 40.9% | ||
| Q2 25 | 7.6% | 60.1% | ||
| Q1 25 | 2.1% | 23.9% | ||
| Q4 24 | 1.1% | 28.9% | ||
| Q3 24 | -5.5% | 25.4% | ||
| Q2 24 | -1.8% | 1.2% | ||
| Q1 24 | -5.3% | -23.6% |
净利率AAMERIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 1.1% | 40.2% | ||
| Q2 25 | 6.0% | 58.6% | ||
| Q1 25 | 1.6% | 21.5% | ||
| Q4 24 | 0.8% | 24.9% | ||
| Q3 24 | -4.5% | 22.5% | ||
| Q2 24 | -1.4% | -2.8% | ||
| Q1 24 | -4.3% | -27.9% |
每股收益（稀释后）AAMERIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | $0.02 | $1.46 | ||
| Q2 25 | $0.15 | $3.28 | ||
| Q1 25 | $0.03 | $0.63 | ||
| Q4 24 | $0.01 | $0.82 | ||
| Q3 24 | $-0.10 | $0.70 | ||
| Q2 24 | $-0.04 | $-0.06 | ||
| Q1 24 | $-0.10 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.4M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $109.5M | $391.5M |
| 总资产 | $430.9M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资AAMERIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | $34.4M | $137.1M | ||
| Q2 25 | $46.4M | $108.4M | ||
| Q1 25 | $35.9M | $77.1M | ||
| Q4 24 | $35.6M | $77.3M | ||
| Q3 24 | $23.0M | $61.1M | ||
| Q2 24 | $21.2M | $49.1M | ||
| Q1 24 | $21.2M | $49.5M |
总债务AAMERIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益AAMERIGL
| Q4 25 | — | $391.5M | ||
| Q3 25 | $109.5M | $117.6M | ||
| Q2 25 | $106.2M | $81.9M | ||
| Q1 25 | $102.4M | $18.6M | ||
| Q4 24 | $99.6M | $3.3M | ||
| Q3 24 | $105.8M | $-14.6M | ||
| Q2 24 | $100.7M | $-29.9M | ||
| Q1 24 | $102.8M | $-31.7M |
总资产AAMERIGL
| Q4 25 | — | $513.6M | ||
| Q3 25 | $430.9M | $242.5M | ||
| Q2 25 | $429.3M | $206.7M | ||
| Q1 25 | $388.4M | $176.0M | ||
| Q4 24 | $393.4M | $164.0M | ||
| Q3 24 | $387.0M | $139.4M | ||
| Q2 24 | $386.0M | $128.4M | ||
| Q1 24 | $365.8M | $126.5M |
负债/权益比AAMERIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $6.6M | — |
| 自由现金流率自由现金流/营收 | 12.3% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | 11.51× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $19.3M | — |
8季度趋势，按日历期对齐
经营现金流AAMERIGL
| Q4 25 | — | $22.0M | ||
| Q3 25 | $6.6M | $24.0M | ||
| Q2 25 | $9.3M | $30.5M | ||
| Q1 25 | $-722.0K | $-893.0K | ||
| Q4 24 | $4.8M | $14.5M | ||
| Q3 24 | $90.0K | $21.7M | ||
| Q2 24 | $416.0K | $302.0K | ||
| Q1 24 | $-5.3M | $-5.0M |
自由现金流AAMERIGL
| Q4 25 | — | — | ||
| Q3 25 | $6.6M | — | ||
| Q2 25 | $9.1M | — | ||
| Q1 25 | $-986.0K | — | ||
| Q4 24 | $4.6M | — | ||
| Q3 24 | $58.0K | — | ||
| Q2 24 | $361.0K | — | ||
| Q1 24 | $-5.4M | — |
自由现金流率AAMERIGL
| Q4 25 | — | — | ||
| Q3 25 | 12.3% | — | ||
| Q2 25 | 16.5% | — | ||
| Q1 25 | -2.0% | — | ||
| Q4 24 | 9.3% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | -11.4% | — |
资本支出强度AAMERIGL
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率AAMERIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 11.51× | 0.86× | ||
| Q2 25 | 2.80× | 0.51× | ||
| Q1 25 | -0.90× | -0.08× | ||
| Q4 24 | 11.65× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AAME
| Bankers Fidelity | $30.0M | 56% |
| American Southern | $23.7M | 44% |
RIGL
暂无分部数据
